Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BTCTW
13876
DELISTED
BTC Digital Ltd. Warrant
BTCTW
| $827 | ﹤0.01% |
46,220
-25,896
| -36% | -$606 |
2024 Q1
2 quarters
|
|
|
HITI
13877
PUT
High Tide
HITI
$241M
| $820 | ﹤0.01% |
400
-4,100
| -91% | -$8.11K |
2022 Q4
7 quarters
|
|
13878
MultiSensor AI Holdings Warrant
MSAIW
| $816 | ﹤0.01% |
32,241
| – | – |
2023 Q4
3 quarters
|
|
13879
NovoCure
NVCR
$1.74B
| $813 | ﹤0.01% |
52
-516,811
| -100% | -$9.37M |
2016 Q4
31 quarters
|
|
|
ENSV
13880
CALL
DELISTED
Enservco Corp.
ENSV
| $793 | ﹤0.01% |
+6,100
| New | +$1.03K |
2024 Q3
0 quarters
|
|
13881
CALL
Mind CTI
MNDO
$20.2M
| $792 | ﹤0.01% |
400
-2,200
| -85% | -$4.17K |
2023 Q4
3 quarters
|
|
13882
SHF Holdings Warrants
SHFSW
$143K
| $788 | ﹤0.01% |
22,503
-100
| -0.4% | -$4 |
2024 Q1
2 quarters
|
|
13883
PUT
ProShares UltraShort Semiconductors
SSG
$33.6M
| $774 | ﹤0.01% |
+6
| New | +$911 |
2024 Q3
0 quarters
|
|
13884
PUT
Tenaya Therapeutics
TNYA
$124M
| $772 | ﹤0.01% |
400
-200
| -33% | -$565 |
2024 Q1
2 quarters
|
|
|
CCGWW
13885
Cheche Group Inc Warrant
CCGWW
$165K
| $761 | ﹤0.01% |
48,499
+6,041
| +14% | +$169 |
2024 Q2
1 quarter
|
|
|
ZEPP
13886
CALL
Zepp Health
ZEPP
$56.2M
| $761 | ﹤0.01% |
175
-2,400
| -93% | -$6.76K |
2022 Q4
7 quarters
|
|
|
NVVEW
13887
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
| $734 | ﹤0.01% |
+28,902
| New | +$575 |
2024 Q3
0 quarters
|
|
|
CHMI
13888
CALL
Cherry Hill Mortgage Investment Corp
CHMI
$97.2M
| $726 | ﹤0.01% |
200
| – | – |
2024 Q2
1 quarter
|
|
|
EMX
13889
CALL
DELISTED
EMX Royalty
EMX
| $712 | ﹤0.01% |
400
-30,900
| -99% | -$55K |
2022 Q4
7 quarters
|
|
|
DDL
13890
CALL
Dingdong
DDL
$470M
| $710 | ﹤0.01% |
+200
| New | +$439 |
2024 Q3
0 quarters
|
|
|
GAN
13891
PUT
DELISTED
GAN Ltd
GAN
| $708 | ﹤0.01% |
+400
| New | +$659 |
2024 Q3
0 quarters
|
|
13892
Candel Therapeutics
CADL
$774M
| $700 | ﹤0.01% |
+101
| New | +$627 |
2024 Q3
0 quarters
|
|
13893
PUT
Neuropace
NPCE
$442M
| $697 | ﹤0.01% |
100
-200
| -67% | -$1.46K |
2024 Q1
2 quarters
|
|
|
NIU
13894
PUT
Niu Technologies
NIU
$153M
| $690 | ﹤0.01% |
+300
| New | +$580 |
2024 Q3
0 quarters
|
|
|
YSG
13895
PUT
Yatsen Holding
YSG
$249M
| $682 | ﹤0.01% |
200
+100
| +100% | +$345 |
2020 Q4
15 quarters
|
|
13896
CALL
CI&T Inc
CINT
$415M
| $679 | ﹤0.01% |
+100
| New | +$638 |
2024 Q3
0 quarters
|
|
|
BMTX.WS
13897
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
| $676 | ﹤0.01% |
21,812
+3,369
| +18% | +$148 |
2024 Q2
1 quarter
|
|
|
RENEW
13898
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
| $659 | ﹤0.01% |
10,981
-125
| -1% | -$10 |
2024 Q2
1 quarter
|
|
13899
CALL
Peoples Financial Services
PFIS
$691M
| $656 | ﹤0.01% |
+14
| New | +$644 |
2024 Q3
0 quarters
|
|
13900
PUT
Culp Inc
CULP
$49.7M
| $655 | ﹤0.01% |
+100
| New | +$519 |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.